Skip to main content
Top
Published in: Breast Cancer Research 5/2014

Open Access 01-10-2014 | Research article

RETRACTED ARTICLE: Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis

Authors: Jun-Tang Li, Li-Feng Wang, Ya-Li Zhao, Tao Yang, Wei Li, Jing Zhao, Feng Yu, Lei Wang, Yan-Ling Meng, Ning-Ning Liu, Xiao-Shan Zhu, Chun-Fang Gao, Lin-Tao Jia, An-Gang Yang

Published in: Breast Cancer Research | Issue 5/2014

Login to get access

Abstract

Introduction

The onset of distal metastasis, which underlies the high mortality of breast cancers, warrants substantial studies to depict its molecular basis. Nuclear factor of activated T cells 5 (NFAT5) is upregulated in various malignancies and is critically involved in migration and invasion of neoplastic cells. Nevertheless, the metastasis-related events potentiated by this transcriptional factor and the mechanism responsible for NFAT5 elevation in carcinoma cells remain to be fully elucidated.

Methods

The correlation of NFAT5 with breast cancer invasiveness was investigated in vitro and clinically. The genes transcriptionally activated by NFAT5 were probed and their roles in breast cancer progression were dissected. The upstream regulators of NFAT5 were studied with particular attempt to explore the involvement of non-coding RNAs, and the mechanism underlying the maintenance of NFAT5 expression was deciphered.

Results

In metastatic breast cancers, NFAT5 promotes epithelial-mesenchymal transition (EMT) and invasion of cells by switching on the expression of the calcium binding protein S100A4, and facilitates the angiogenesis of breast epithelial cells and thus the development of metastases by transcriptionally activating vascular endothelial growth factor C (VEGF-C). NFAT5 is directly targeted by miR-568, which is in turn suppressed by the long non-coding RNA, Hotair, via a documented in trans gene silencing pattern, that is recruitment of the polycomb complex (Polycomb Repressive Complex 2; PRC2) and LSD1, and consequently methylation of histone H3K27 and demethylation of H3K4 on the miR-568 loci.

Conclusion

This study unravels a detailed role of NFAT5 in mediating metastatic signaling, and provides broad insights into the involvement of Hotair, in particular, by transcriptionally regulating the expression of microRNA(s), in the metastasis of breast cancers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lorusso G, Rüegg C: New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol. 2012, 22: 226-233. 10.1016/j.semcancer.2012.03.007.CrossRefPubMed Lorusso G, Rüegg C: New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol. 2012, 22: 226-233. 10.1016/j.semcancer.2012.03.007.CrossRefPubMed
2.
go back to reference Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science. 2011, 331: 1559-1564. 10.1126/science.1203543.CrossRefPubMed Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science. 2011, 331: 1559-1564. 10.1126/science.1203543.CrossRefPubMed
3.
go back to reference Gupta GP, Massagué J: Cancer metastasis: building a framework. Cell. 2006, 127: 679-695. 10.1016/j.cell.2006.11.001.CrossRefPubMed Gupta GP, Massagué J: Cancer metastasis: building a framework. Cell. 2006, 127: 679-695. 10.1016/j.cell.2006.11.001.CrossRefPubMed
4.
go back to reference Nguyen DX, Bos PD, Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009, 9: 274-284. 10.1038/nrc2622.CrossRefPubMed Nguyen DX, Bos PD, Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009, 9: 274-284. 10.1038/nrc2622.CrossRefPubMed
7.
go back to reference Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A: The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002, 4: 540-544. 10.1038/ncb816.CrossRefPubMed Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A: The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002, 4: 540-544. 10.1038/ncb816.CrossRefPubMed
9.
go back to reference Müller MR, Rao A: NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol. 2010, 10: 645-656. 10.1038/nri2818.CrossRefPubMed Müller MR, Rao A: NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol. 2010, 10: 645-656. 10.1038/nri2818.CrossRefPubMed
10.
go back to reference Germann S, Gratadou L, Zonta E, Dardenne E, Gaudineau B, Fougère M, Samaan S, Dutertre M, Jauliac S, Auboeuf D: Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor. Oncogene. 2012, 31: 4536-4549. 10.1038/onc.2011.618.CrossRefPubMed Germann S, Gratadou L, Zonta E, Dardenne E, Gaudineau B, Fougère M, Samaan S, Dutertre M, Jauliac S, Auboeuf D: Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor. Oncogene. 2012, 31: 4536-4549. 10.1038/onc.2011.618.CrossRefPubMed
11.
go back to reference Mishra SK, Siddique HR, Saleem M: S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 2012, 31: 163-172. 10.1007/s10555-011-9338-4.CrossRefPubMed Mishra SK, Siddique HR, Saleem M: S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 2012, 31: 163-172. 10.1007/s10555-011-9338-4.CrossRefPubMed
12.
go back to reference Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 2007, 96: 541-545. 10.1038/sj.bjc.6603487.CrossRefPubMed Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 2007, 96: 541-545. 10.1038/sj.bjc.6603487.CrossRefPubMed
13.
go back to reference Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010, 329: 689-693. 10.1126/science.1192002.CrossRefPubMedPubMedCentral Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010, 329: 689-693. 10.1126/science.1192002.CrossRefPubMedPubMedCentral
14.
go back to reference Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY: Long non-coding RNA Hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010, 464: 1071-1076. 10.1038/nature08975.CrossRefPubMedPubMedCentral Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY: Long non-coding RNA Hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010, 464: 1071-1076. 10.1038/nature08975.CrossRefPubMedPubMedCentral
15.
go back to reference Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007, 129: 1311-1323. 10.1016/j.cell.2007.05.022.CrossRefPubMedPubMedCentral Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007, 129: 1311-1323. 10.1016/j.cell.2007.05.022.CrossRefPubMedPubMedCentral
16.
go back to reference Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA: MicroRNAs–the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009, 9: 293-302. 10.1038/nrc2619.CrossRefPubMed Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA: MicroRNAs–the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009, 9: 293-302. 10.1038/nrc2619.CrossRefPubMed
17.
go back to reference Zhang H, Li Y, Lai M: The microRNA network and tumor metastasis. Oncogene. 2010, 29: 937-948. 10.1038/onc.2009.406.CrossRefPubMed Zhang H, Li Y, Lai M: The microRNA network and tumor metastasis. Oncogene. 2010, 29: 937-948. 10.1038/onc.2009.406.CrossRefPubMed
18.
go back to reference Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B: Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001, 15: 2069-2082. 10.1101/gad.906601.CrossRefPubMedPubMedCentral Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B: Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001, 15: 2069-2082. 10.1101/gad.906601.CrossRefPubMedPubMedCentral
19.
go back to reference Zhao Y, Tan YZ, Zhou LF, Wang HJ, Mao Y: Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Stroke. 2007, 38: 1313-1319. 10.1161/01.STR.0000259914.21997.89.CrossRefPubMed Zhao Y, Tan YZ, Zhou LF, Wang HJ, Mao Y: Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Stroke. 2007, 38: 1313-1319. 10.1161/01.STR.0000259914.21997.89.CrossRefPubMed
20.
go back to reference Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL: Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem. 2009, 284: 1484-1494. 10.1074/jbc.M803997200.CrossRefPubMedPubMedCentral Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL: Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem. 2009, 284: 1484-1494. 10.1074/jbc.M803997200.CrossRefPubMedPubMedCentral
21.
go back to reference Wiig H, Schröder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, Boschmann M, Goss J, Bry M, Rakova N, Dahlmann A, Brenner S, Tenstad O, Nurmi H, Mervaala E, Wagner H, Beck FX, Müller DN, Kerjaschki D, Luft FC, Harrison DG, Alitalo K, Titze J: Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 2013, 123: 2803-2815. 10.1172/JCI60113.CrossRefPubMedPubMedCentral Wiig H, Schröder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, Boschmann M, Goss J, Bry M, Rakova N, Dahlmann A, Brenner S, Tenstad O, Nurmi H, Mervaala E, Wagner H, Beck FX, Müller DN, Kerjaschki D, Luft FC, Harrison DG, Alitalo K, Titze J: Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 2013, 123: 2803-2815. 10.1172/JCI60113.CrossRefPubMedPubMedCentral
22.
go back to reference Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9: 265-273. 10.1038/nrc2620.CrossRefPubMed Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9: 265-273. 10.1038/nrc2620.CrossRefPubMed
23.
go back to reference Li W, Kong LB, Li JT, Guo ZY, Xue Q, Yang T, Meng YL, Jin BQ, Wen WH, Yang AG: MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5. Int Immunol. 2014, 26: 269-281. 10.1093/intimm/dxt065.CrossRefPubMed Li W, Kong LB, Li JT, Guo ZY, Xue Q, Yang T, Meng YL, Jin BQ, Wen WH, Yang AG: MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5. Int Immunol. 2014, 26: 269-281. 10.1093/intimm/dxt065.CrossRefPubMed
24.
go back to reference Buxadé M, Lunazzi G, Minguillón J, Iborra S, Berga-Bolaños R, Del Val M, Aramburu J, López-Rodriguez C: Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med. 2012, 209: 379-393. 10.1084/jem.20111569.CrossRefPubMedPubMedCentral Buxadé M, Lunazzi G, Minguillón J, Iborra S, Berga-Bolaños R, Del Val M, Aramburu J, López-Rodriguez C: Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med. 2012, 209: 379-393. 10.1084/jem.20111569.CrossRefPubMedPubMedCentral
25.
go back to reference Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009, 15: 545-552. 10.1038/nm.1960.CrossRefPubMed Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009, 15: 545-552. 10.1038/nm.1960.CrossRefPubMed
26.
go back to reference Roth I, Leroy V, Kwon HM, Martin PY, Féraille E, Hasler U: Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol Biol Cell. 2010, 21: 3459-3474. 10.1091/mbc.E10-02-0133.CrossRefPubMedPubMedCentral Roth I, Leroy V, Kwon HM, Martin PY, Féraille E, Hasler U: Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol Biol Cell. 2010, 21: 3459-3474. 10.1091/mbc.E10-02-0133.CrossRefPubMedPubMedCentral
27.
go back to reference Feng LZ, Zheng XY, Zhou LX, Fu B, Yu YW, Lu SC, Cao NS: Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. J Int Med Res. 2011, 39: 1333-1343. 10.1177/147323001103900420.CrossRefPubMed Feng LZ, Zheng XY, Zhou LX, Fu B, Yu YW, Lu SC, Cao NS: Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. J Int Med Res. 2011, 39: 1333-1343. 10.1177/147323001103900420.CrossRefPubMed
28.
go back to reference Wang L, Wang J: MicroRNA-mediated breast cancer metastasis: from primary site to distant organs. Oncogene. 2012, 31: 2499-2511. 10.1038/onc.2011.444.CrossRefPubMed Wang L, Wang J: MicroRNA-mediated breast cancer metastasis: from primary site to distant organs. Oncogene. 2012, 31: 2499-2511. 10.1038/onc.2011.444.CrossRefPubMed
29.
go back to reference Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF, Wang NS: Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J Nephrol. 2012, 25: 566-576. 10.5301/jn.5000034.CrossRefPubMed Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF, Wang NS: Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J Nephrol. 2012, 25: 566-576. 10.5301/jn.5000034.CrossRefPubMed
30.
31.
go back to reference Garcia-Closas M, Chanock S: Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res. 2008, 14: 8000-8009. 10.1158/1078-0432.CCR-08-0975.CrossRefPubMedPubMedCentral Garcia-Closas M, Chanock S: Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res. 2008, 14: 8000-8009. 10.1158/1078-0432.CCR-08-0975.CrossRefPubMedPubMedCentral
32.
go back to reference Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000, 19: 6102-6114. 10.1038/sj.onc.1203973.CrossRefPubMed Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000, 19: 6102-6114. 10.1038/sj.onc.1203973.CrossRefPubMed
33.
go back to reference Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC: Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012, 131: 159-167. 10.1007/s10549-011-1702-0.CrossRefPubMed Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC: Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012, 131: 159-167. 10.1007/s10549-011-1702-0.CrossRefPubMed
34.
go back to reference Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L: Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011, 9: 16-32. 10.1038/nrclinonc.2011.177.CrossRefPubMed Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L: Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011, 9: 16-32. 10.1038/nrclinonc.2011.177.CrossRefPubMed
35.
go back to reference Jordan VC, O'Malley BW: Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol. 2007, 25: 5815-5824. 10.1200/JCO.2007.11.3886.CrossRefPubMed Jordan VC, O'Malley BW: Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol. 2007, 25: 5815-5824. 10.1200/JCO.2007.11.3886.CrossRefPubMed
36.
go back to reference Pal SK, Childs BH, Pegram M: Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2011, 125: 627-636. 10.1007/s10549-010-1293-1.CrossRefPubMed Pal SK, Childs BH, Pegram M: Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2011, 125: 627-636. 10.1007/s10549-010-1293-1.CrossRefPubMed
37.
go back to reference Scheel C, Weinberg RA: Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012, 22: 396-403. 10.1016/j.semcancer.2012.04.001.CrossRefPubMedPubMedCentral Scheel C, Weinberg RA: Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012, 22: 396-403. 10.1016/j.semcancer.2012.04.001.CrossRefPubMedPubMedCentral
Metadata
Title
RETRACTED ARTICLE: Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis
Authors
Jun-Tang Li
Li-Feng Wang
Ya-Li Zhao
Tao Yang
Wei Li
Jing Zhao
Feng Yu
Lei Wang
Yan-Ling Meng
Ning-Ning Liu
Xiao-Shan Zhu
Chun-Fang Gao
Lin-Tao Jia
An-Gang Yang
Publication date
01-10-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-014-0454-2

Other articles of this Issue 5/2014

Breast Cancer Research 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine